| 2026-10-22 16:45 |
8-K |
["7.01", "9.01"] |
other |
0.02
|
Routine 8-K disclosure of patient education webinar; no M&A signals present. |
SEC · detail |
| 2026-10-14 08:00 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine 8-K announcing press release about TULSA-PRO system abstracts at medical symposium; no M&A signal. |
SEC · detail |
| 2026-10-09 13:11 |
8-K |
["7.01", "9.01"] |
material agreement |
0.15
|
Co-education agreement with Telix Pharmaceuticals; no M&A implications evident. |
SEC · detail |
| 2026-10-07 16:45 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with business update; no M&A signals present. |
SEC · detail |
| 2026-09-03 21:00 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine conference participation announcement with no M&A indicators. |
SEC · detail |
| 2026-09-03 07:07 |
8-K |
["5.02", "7.01", "9.01"] |
officer change |
0.15
|
Executive appointment of experienced healthcare industry veteran as President; insufficient signal for M&A activity. |
SEC · detail |
| 2026-08-17 08:35 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Press release announcing new MRI software product; routine disclosure unrelated to M&A. |
SEC · detail |
| 2026-08-17 07:30 |
8-K |
["5.02", "7.01", "9.01"] |
officer change |
0.35
|
CFO departure and interim appointment; limited M&A signal without explicit strategic review or transaction language. |
SEC · detail |
| 2026-08-13 16:30 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
8-K announces patient advocacy initiative; no M&A-related activity indicated. |
SEC · detail |
| 2026-08-06 16:20 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with business update; no M&A signals present. |
SEC · detail |
| 2026-07-24 11:58 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine press release announcing clinical trial data; no M&A signals present. |
SEC · detail |
| 2026-07-16 16:45 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine Q2 earnings announcement with conference call scheduled; no M&A signals present. |
SEC · detail |
| 2026-07-15 08:00 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine press release announcing product presentations at industry conference; no M&A signals. |
SEC · detail |
| 2026-05-15 16:06 |
8-K |
["5.07", "9.01"] |
other |
0.05
|
Routine 8-K filing of annual shareholder meeting results; no M&A signals detected. |
SEC · detail |
| 2026-05-14 17:06 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine disclosure of TULSA Procedure presentations at medical conference; no M&A indicators present. |
SEC · detail |
| 2026-05-07 16:12 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with business update; no M&A signals detected. |
SEC · detail |